These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Microbiome Engineering Using Probiotic Yeast: Kim J; Atkinson C; Miller MJ; Kim KH; Jin YS Microbiol Spectr; 2023 Aug; 11(4):e0078023. PubMed ID: 37436157 [TBL] [Abstract][Full Text] [Related]
5. Saccharomyces boulardii CNCM I-745 probiotic does not alter the pharmacokinetics of amoxicillin. Selig DJ; DeLuca JP; Li Q; Lin H; Nguyen K; Scott SM; Sousa JC; Vuong CT; Xie LH; Livezey JR Drug Metab Pers Ther; 2020 Mar; 35(1):. PubMed ID: 32134728 [TBL] [Abstract][Full Text] [Related]
6. Unique genetic basis of the distinct antibiotic potency of high acetic acid production in the probiotic yeast Offei B; Vandecruys P; De Graeve S; Foulquié-Moreno MR; Thevelein JM Genome Res; 2019 Sep; 29(9):1478-1494. PubMed ID: 31467028 [TBL] [Abstract][Full Text] [Related]
7. Treatment of murine colitis by Saccharomyces boulardii secreting atrial natriuretic peptide. Liu CH; Chang JH; Chang YC; Mou KY J Mol Med (Berl); 2020 Dec; 98(12):1675-1687. PubMed ID: 33025105 [TBL] [Abstract][Full Text] [Related]
8. Duysburgh C; Van den Abbeele P; Morera M; Marzorati M Benef Microbes; 2021 Aug; 12(4):59-73. PubMed ID: 34190033 [TBL] [Abstract][Full Text] [Related]
9. Unique Probiotic Properties and Bioactive Metabolites of Saccharomyces boulardii. Fu J; Liu J; Wen X; Zhang G; Cai J; Qiao Z; An Z; Zheng J; Li L Probiotics Antimicrob Proteins; 2023 Aug; 15(4):967-982. PubMed ID: 35608794 [TBL] [Abstract][Full Text] [Related]
10. [A multicenter randomized controlled study of Wan CM; Yu H; Liu G; Xu HM; Mao ZQ; Xu Y; Jin Y; Luo RP; Wang WJ; Fang F Zhonghua Er Ke Za Zhi; 2017 May; 55(5):349-354. PubMed ID: 28482385 [No Abstract] [Full Text] [Related]
11. Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS. Brun P; Scarpa M; Marchiori C; Sarasin G; Caputi V; Porzionato A; Giron MC; Palù G; Castagliuolo I PLoS One; 2017; 12(7):e0181863. PubMed ID: 28732069 [TBL] [Abstract][Full Text] [Related]
12. Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers. Kabbani TA; Pallav K; Dowd SE; Villafuerte-Galvez J; Vanga RR; Castillo NE; Hansen J; Dennis M; Leffler DA; Kelly CP Gut Microbes; 2017 Jan; 8(1):17-32. PubMed ID: 27973989 [TBL] [Abstract][Full Text] [Related]
13. Saccharomyces boulardii ameliorates gut dysbiosis associated cognitive decline. Roy Sarkar S; Mitra Mazumder P; Chatterjee K; Sarkar A; Adhikary M; Mukhopadhyay K; Banerjee S Physiol Behav; 2021 Jul; 236():113411. PubMed ID: 33811908 [TBL] [Abstract][Full Text] [Related]
14. Saccharomyces boulardii CNCM I-745: A Non-bacterial Microorganism Used as Probiotic Agent in Supporting Treatment of Selected Diseases. Kaźmierczak-Siedlecka K; Ruszkowski J; Fic M; Folwarski M; Makarewicz W Curr Microbiol; 2020 Sep; 77(9):1987-1996. PubMed ID: 32472262 [TBL] [Abstract][Full Text] [Related]
15. Fungemia following Saccharomyces cerevisiae var. boulardii probiotic treatment in an elderly patient. Landaburu MF; López Daneri GA; Relloso S; Zarlenga LJ; Vinante MA; Mujica MT Rev Argent Microbiol; 2020; 52(1):27-30. PubMed ID: 31262611 [TBL] [Abstract][Full Text] [Related]
16. Intestinal anti-inflammatory effect of the probiotic Saccharomyces boulardii in DSS-induced colitis in mice: Impact on microRNAs expression and gut microbiota composition. Rodríguez-Nogales A; Algieri F; Garrido-Mesa J; Vezza T; Utrilla MP; Chueca N; García F; Rodríguez-Cabezas ME; Gálvez J J Nutr Biochem; 2018 Nov; 61():129-139. PubMed ID: 30236870 [TBL] [Abstract][Full Text] [Related]
17. Saccharomyces boulardii as therapeutic alternative in experimental giardiasis. Ribeiro MRS; Oliveira DR; Caliari MV; Cara Machado DC; Andrade MER; Cardoso VN; Dos Santos Martins F; Nicoli JR; Gomes MA J Appl Microbiol; 2021 Jul; 131(1):460-469. PubMed ID: 33289232 [TBL] [Abstract][Full Text] [Related]
18. Epidemiology of Saccharomyces fungemia: A systematic review. Vinayagamoorthy K; Pentapati KC; Prakash H Med Mycol; 2023 Feb; 61(2):. PubMed ID: 36806741 [TBL] [Abstract][Full Text] [Related]
19. Studies on the time course of the effects of the probiotic yeast Saccharomyces boulardii on electrolyte transport in pig jejunum. Schroeder B; Winckler C; Failing K; Breves G Dig Dis Sci; 2004 Aug; 49(7-8):1311-7. PubMed ID: 15387362 [TBL] [Abstract][Full Text] [Related]